HomeHealth articlesfactor v leidenWhat Is Factor V Leiden?

Factor V Leiden - Exploring the Condition

Verified dataVerified data
0

4 min read

Share

Read this article to learn more about factor V Leiden, a mutated clotting factor that may raise the risk of deep vein thrombosis or a pulmonary embolism.

Medically reviewed by

Dr. Abdul Aziz Khan

Published At April 4, 2023
Reviewed AtApril 4, 2023

What Is Clotting Factor V Leiden?

Factor V Leiden is a type of blood coagulation disorder that usually increases the risk of dangerous blood clots in the legs or the lungs. It is a common inherited blood clotting disorder passed down within biologically related families. People diagnosed with factor V Leiden have a mutation in their blood clotting factor V gene. This gene controls the synthesis of factor V, a protein that helps the blood clot when required after an injury. Mutation in the factor V Leiden gene alters the structure of the protein. This alteration in the protein structure causes it to resist other proteins that prevent excessive clotting. As a result, the blood may clot more readily than it should, leading to fatal consequences and serious complications. The incidence of factor V Leiden depends largely on ethnicity. It is more frequently seen among white people in the United States and Europe than black people.

How Does Factor V Leiden Affect the Body?

Factor V Leiden can lead to the development of the following complications in the body:

  • Deep Vein Thrombosis (DVT): The formation of blood clots in the deep veins of the upper and lower extremities is called deep vein thrombosis. Factor V Leiden is strongly associated with deep vein thrombosis. It has been discovered that up to one in five people who develop deep vein thrombosis for the first time exhibit mutation in factor V Leiden.

  • Pulmonary Embolism (PE): When the blood clot travels through the bloodstream to one of the lungs of the patients, it can lead to pulmonary embolism. Factor V Leiden is not strongly associated with pulmonary embolism, but the risk is still high.

However, it is not necessary that people affected with factor V Leiden will always develop deep vein thrombosis or pulmonary embolism. Most people do not develop such abnormal blood clots. However, this clotting disorder can raise the risk of developing these complications compared to people not affected by the disorder.

If a person is affected by this disorder, he or she may experience the following:

  • Multiple episodes of deep vein thrombosis or pulmonary embolism before 50 years.

  • Blood clots in rarely affected veins, like those in the liver, kidneys, intestines, or brain.

  • Development of pulmonary embolism or deep vein thrombosis during or post pregnancy.

  • Abnormal clot formation soon after taking birth control pills or hormonal therapy.

However, Factor V Leiden does not increase the risk of heart attacks, ischemic strokes, or blood clots formed in the arteries of the legs.

What Is the Cause of Factor V Leiden?

Gene mutation (alteration) causes factor V Leiden. People affected with this condition have a genetic mutation in the coagulation factor V. This gene is responsible for carrying instructions to the body to properly synthesize the protein factor V. It is an autosomal dominant genetic disorder.

What Are the Risk Factors?

The person is at risk in the following situations;

  • If any one of the parents carries a copy of the mutated factor V gene.

  • Additional genetic blood coagulation disorders.

  • Recent surgery.

  • Pregnancy.

  • Taking hormone-based therapies.

What Are the Clinical Symptoms of Factor V Leiden?

The hereditary condition does not cause any symptoms on its own. However, some people with this disorder develop dangerous blood clots in the legs or lungs.

Clinical symptoms of deep vein thrombosis include:

  • Swollen and inflamed arms or legs.

  • Pain in the legs and arms.

  • Larger veins than normal near the surface of the skin.

  • Pain in the belly if the veins of the belly are affected.

  • Severe headache.

  • Seizures if blood clots affect the veins of the brain.

Clinical symptoms of a pulmonary embolism include:

  • Sudden breathlessness.

  • Sharp pain in the chest that worsens on sneezing or coughing.

  • Wheezing (sharp whistling sound).

  • Rapid heartbeat.

  • Anxiety.

  • Lightheadedness.

How Is Factor V Leiden Diagnosed?

Blood tests are required to diagnose this disorder. The healthcare provider may suspect factor V Leiden if the patient has a history of pulmonary thromboembolism. He may also suspect this disorder if his family members have a history of blood clot formation. The following tests can be ordered;

  • Activated Protein C Blood Test: This is a screening test for coagulation factors to check if the blood resists activated protein C (a protein used to prevent factor V from overperforming).

  • Genetic Tests: If the patient’s blood is resistant to activated protein C, the doctor can order a genetic test to check the mutation in the F5 gene for the coagulation factor V Leiden.

How Is Factor V Leiden Treated?

There is no specific cure for factor V Leiden mutation. Treatment with blood thinners (anticoagulants) is necessary if a person is diagnosed with deep vein thrombosis or pulmonary embolism. The treatment should be started as soon as possible. The patient may even require hospitalization, depending on the severity of the symptoms.

Individuals with factor V Leiden who never experienced blood clots should not be prescribed anticoagulants.

What Is the Major Difference Between Factor V and Factor V Leiden?

The production and synthesis of factor V are controlled by the F5 gene. Factor V is mainly responsible to help in blood clotting, particularly after an injury. The genetic mutation in the factor V Leiden alters the structure of this protein component. This alteration in the protein structure causes it to resist other clotting factors that help in excessive coagulation.

What to Avoid With Factor V Leiden?

The patient should avoid the following:

  • Chronic smoking.

  • Tobacco use.

  • Long sitting periods.

  • Excessive alcohol consumption.

  • Birth control pills consumption or hormone therapy to control symptoms of menopause.

Conclusion

Factor V Leiden is a hereditary blood clotting disorder. If a patient develops serious symptoms of deep vein thrombosis and pulmonary embolism, the patient should seek immediate medical help. The complications can be life-threatening. However, most people with this disorder do not develop a blood clot. Therefore, it is not a very high-risk factor. Patients having heterozygous factor V Leiden do not develop dangerous blood clots.

Frequently Asked Questions

1.

Does Factor V Constitute a Bleeding Disorder?

Factor V Leiden is a genetic mutation that influences blood clotting regulation. While it does not typically qualify as a traditional bleeding disorder, it does disrupt the delicate balance between clot formation and dissolution. This mutation increases the likelihood of abnormal clotting, which can lead to conditions like deep vein thrombosis (DVT) and pulmonary embolism.

2.

By What Other Name Is Coagulation Factor V Recognized?

Coagulation Factor V is alternatively referred to as Proaccelerin or Labile Factor. This clotting factor plays a pivotal role in the intricate coagulation cascade. It aids in the conversion of prothrombin to thrombin, a critical step in the formation of fibrin, the protein mesh that reinforces blood clots.

3.

What Function Does Factor V Serve in the Process of Blood Coagulation?

Factor V is a linchpin in blood clotting. Acting as a cofactor, it accelerates the transformation of prothrombin to thrombin. Thrombin, in turn, triggers the conversion of fibrinogen to fibrin, leading to clot development. This orchestration ensures proper hemostasis – the body's ability to halt bleeding while maintaining circulation.

4.

Could You Elucidate a Coagulation Disorder That Pertains to Clotting Factors?

Coagulation disorders encompass a range of conditions that disrupt the body's clotting processes. These can result from deficiencies or malfunctions in various clotting factors. Hemophilia and von Willebrand disease are prime examples, characterized by insufficient clotting factor VIII and von Willebrand factor, respectively.

5.

Is Hemophilia Categorized as a Type of Coagulation Disorder?

Yes, hemophilia is a quintessential coagulation disorder. It manifests due to deficiencies in clotting factors, rendering blood clot formation inefficient. Hemophilia A (lack of factor VIII) and hemophilia B (lack of factor IX) demonstrate the integral role of clotting factors in preventing excessive bleeding.

6.

Can You Provide an Illustration of a Coagulation Factor?

Coagulation Factor II, also known as prothrombin, exemplifies a significant clotting factor. This precursor protein, when converted to thrombin, ignites a cascade of reactions leading to the creation of fibrin strands, thereby stabilizing the blood clot.
 

7.

Is It Feasible for Pregnancies to Proceed Without Complications in the Presence of Factor V Leiden?

Many individuals with Factor V Leiden can experience successful pregnancies, although it presents an increased risk of thrombotic events. Proper prenatal care, monitoring, and sometimes anticoagulant medications are employed to minimize clotting risks and ensure a safe pregnancy outcome.

8.

Is Excessive Clotting During Pregnancy Indicative of an Increased Risk of Miscarriage?

Heavy clotting during pregnancy could signal potential complications, including an increased risk of miscarriage. The excessive clotting could disrupt blood flow to the developing fetus or placenta, necessitating close medical monitoring and intervention.

9.

How Does the Clotting of Blood Impact the Developing Fetus?

Aberrant blood clotting can detrimentally impact fetal development by hindering optimal blood flow through the placenta. This compromised blood circulation may lead to inadequate nutrient and oxygen delivery, potentially resulting in fetal growth restrictions or other adverse outcomes.

10.

Can Factor V Leiden Be Passed Down Through Multiple Generations?

Factor V Leiden's inheritance pattern can indeed skip generations. This depends on whether individuals who carry the mutation have children with individuals who do not possess the mutation, thereby affecting the likelihood of its transmission.

11.

What Determines the Inheritance Pattern of Factor V Leiden?

Factor V Leiden follows an autosomal dominant inheritance pattern. This means that inheriting a single copy of the mutated gene from either parent is sufficient to express the condition. Individuals with one copy of the mutated gene are at risk of developing clotting issues.

12.

What Preventive Measures Can Be Employed to Mitigate Complications Associated with Factor V Leiden?

Mitigating complications of Factor V Leiden involves adopting a healthy lifestyle, avoiding smoking, maintaining physical activity, and adhering to medical advice. Regular medical check-ups ensure prompt identification and management of any clotting-related issues.

13.

Which Anticoagulant Medications Are Typically Prescribed for Individuals with the Factor V Leiden Mutation?

For those with Factor V Leiden, anticoagulants like Heparin and Warfarin may be administered to reduce the risk of clotting. These drugs support the management of related problems and prevent excessive clot formation.

14.

What Are the Treatment Protocols for Deep Vein Thrombosis (DVT) in Individuals Diagnosed with Factor V Leiden?

Treating DVT in individuals with Factor V Leiden necessitates a comprehensive approach. This typically involves anticoagulant therapy to prevent further clot growth, compression stockings to improve blood circulation, and lifestyle adjustments to minimize future clotting risks.

15.

Are Direct Oral Anticoagulants (DOACs) Considered a Suitable Option for Managing Factor V Leiden?

For those with Factor V Leiden, direct oral anticoagulants (DOACs) may be an option for controlling clotting risks. However, a person's health and medical history, as well as other considerations, determine whether DOACs are suitable for them.

16.

Should Individuals with Factor V Leiden Consider the Use of Low-Dose Aspirin?

The decision to take baby Aspirin or any medication should be made in consultation with a healthcare provider. It is important to weigh the potential benefits against the risks, considering an individual's overall health and clotting risk factors.

17.

What Anticoagulation Therapy Is Recommended for Individuals with Factor V Leiden?

Depending on the patient's unique situation, several anticoagulant therapies can be used to treat Factor V Leiden. The treatment strategy is customized by medical specialists to the unique clotting risk profile, even though choices like Heparin or Warfarin may be taken into account.

18.

Is There Any Correlation Between Varicose Veins and an Increased Risk of Blood Clots?

Although varicose veins by themselves are not associated with an elevated risk of blood clots, they may raise a person's total risk. This is especially important when taking into account elements like hereditary propensity and prolonged immobility.
Source Article IclonSourcesSource Article Arrow
Dr. Abdul Aziz Khan
Dr. Abdul Aziz Khan

Medical oncology

Tags:

factor v leiden
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

factor v leiden

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy